Medicare Enrolled
Dr. Irena Pleskova, MD
Hematology & Oncology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pleskova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pleskova?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pleskova
Dr. Irena Pleskova is a hematology & oncology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pleskova performed 13,966 Medicare services across 2,983 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pleskova received a total of $11,724 from 61 pharmaceutical and/or device companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pleskova is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in NY
$11,724 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,966
Medicare services
Top 21% in NY for hematology & oncology
2,983
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~698 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
2,895 | $56 | $73 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
2,726 | $45 | $57 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
2,503 | $47 | $61 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,772 | $81 | $107 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
686 | $8 | $9 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
573 | $13 | $17 |
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 457 | $2 | $2 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
347 | $0 | $1 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $51 | $68 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
310 | $13 | $17 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
208 | $61 | $78 |
| Lactated Ringer's infusion, up to 1000 cc Intravenous administration of Lactated Ringer's solution, a fluid used to replace fluids and electrolytes, in amounts up to 1000 cubic centimeters. |
152 | $2 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
130 | $1 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $112 | $151 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
121 | $29 | $39 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
102 | $1 | $1 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
93 | $99 | $135 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
81 | $54 | $73 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
49 | $0 | $1 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
41 | $1 | $1 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
31 | $11 | $16 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 29 | $20 | $21 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
29 | $19 | $24 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
28 | $36 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $144 | $198 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
24 | $19 | $24 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
22 | $0 | $0 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
20 | $9 | $11 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $23 | $28 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $84 | $107 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $47 | $66 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.8% high complexity
9.3% medium
85.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,724
Total received (2018-2024)
Avg $1,675/year across 7 years
Top 23% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
590
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,724 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,952
2023
$2,027
2022
$2,038
2021
$1,660
2020
$840
2019
$974
2018
$1,234
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$608
AstraZeneca Pharmaceuticals LP
$410
Sumitomo Pharma America, Inc.
$252
Merck Sharp & Dohme LLC
$214
Amgen Inc.
$206
AIMMUNE THERAPEUTICS, INC.
$159
Paratek Pharmaceuticals, Inc.
$155
GENZYME CORPORATION
$125
Lexicon Pharmaceuticals, Inc.
$110
Corcept Therapeutics
$104
Janssen Pharmaceuticals, Inc
$97
GlaxoSmithKline, LLC.
$70
Bayer Healthcare Pharmaceuticals Inc.
$53
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
SCILEX PHARMACEUTICALS INC.
$49
SHIELD THERAPEUTICS INC
$46
IRONWOOD PHARMACEUTICALS, INC
$38
Azurity Pharmaceuticals, Inc.
$31
Kowa Pharmaceuticals America, Inc.
$29
Incyte Corporation
$24
Otsuka America Pharmaceutical, Inc.
$24
SOBI, INC
$23
Celgene Corporation
$22
Novo Nordisk Inc
$19
PFIZER INC.
$14
Lilly USA, LLC
$14
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,343
Amgen Inc.
$720
AstraZeneca Pharmaceuticals LP
$593
Amarin Pharma Inc.
$578
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$559
Merck Sharp & Dohme LLC
$478
Nestle HealthCare Nutrition Inc.
$413
GlaxoSmithKline, LLC.
$400
AbbVie Inc.
$388
Sumitomo Pharma America, Inc.
$386
Allergan Inc.
$357
Novartis Pharmaceuticals Corporation
$349
Takeda Pharmaceuticals U.S.A., Inc.
$342
Ironwood Pharmaceuticals, Inc
$327
NESTLE HEALTHCARE NUTRITION INC.
$319
Paratek Pharmaceuticals, Inc.
$317
ARBOR PHARMACEUTICALS, INC.
$267
Kowa Pharmaceuticals America, Inc.
$227
Bayer HealthCare Pharmaceuticals Inc.
$220
Horizon Therapeutics plc
$211
Janssen Pharmaceuticals, Inc
$204
Novo Nordisk Inc
$179
AIMMUNE THERAPEUTICS, INC.
$159
GENZYME CORPORATION
$149
E.R. Squibb & Sons, L.L.C.
$138
Lexicon Pharmaceuticals, Inc.
$132
Lilly USA, LLC
$128
Medtronic, Inc.
$127
IRONWOOD PHARMACEUTICALS, INC
$115
PFIZER INC.
$111
Sunovion Pharmaceuticals Inc.
$107
Corcept Therapeutics
$104
Dova Pharmaceuticals
$91
Allergan, Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$79
IDORSIA PHARMACEUTICALS US INC
$75
Gilead Sciences, Inc.
$73
Nabriva Therapeutics, plc
$62
Janssen Biotech, Inc.
$61
Hikma Pharmaceuticals USA
$50
SCILEX PHARMACEUTICALS INC.
$49
SHIELD THERAPEUTICS INC
$46
Genentech USA, Inc.
$46
AbbVie, Inc.
$46
ASSERTIO THERAPEUTICS, Inc.
$46
Celgene Corporation
$44
Synergy Pharmaceuticals Inc
$41
Merck Sharp & Dohme Corporation
$40
VIVUS LLC
$38
Noden Pharma USA Inc
$37
Nevro Corp.
$34
Azurity Pharmaceuticals, Inc.
$31
Almatica Pharma LLC
$29
Biohaven Pharmaceutical Holding Company Ltd.
$27
Incyte Corporation
$24
Otsuka America Pharmaceutical, Inc.
$24
Scilex Pharmaceuticals Inc.
$23
SOBI, INC
$23
Philips Electronics North America Corporation
$20
IBSA Pharma Inc.
$19
Arbor Pharmaceuticals, Inc.
$19
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACCRUFER · AIRSUPRA · ANORO · APRISO · Aimovig · Amitiza · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BYSTOLIC · CHANTIX · CREON · Creon · DOPTELET · DUPIXENT · Dexilant · Doptelet · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · GEMTESA · GRALISE · Gralise · HORIZANT · Horizant · ILLUMISITE · Inpefa · JAKAFI · JANUVIA · JARDIANCE · KEVZARA · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LYRICA · Licart · Linzess · Livalo · MOUNJARO · Mitigare · Motegrity · NURTEC ODT · NUZYRA · Nplate · Omnia · Otezla · Ozempic · PANCREAZE · PENNSAID · PREVNAR - 13 · Pancreaze · Pomalyst · Prolia · QULIPTA · QUVIVIQ · RAYOS · REBLOZYL · REMICADE · REXULTI · Repatha · SEGLENTIS · STEGLATRO · TEKTURNA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · Uloric · VERQUVO · VIBERZI · VOWST · VRAYLAR · Vascepa · Verquvo · XARELTO · XIFAXAN · Xenleta · Xofluza · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
707
Per 100K population
26.7
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pleskova is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pleskova experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Pleskova performed 2,895 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pleskova receive payments from pharmaceutical companies?
Yes. Dr. Pleskova received a total of $11,724 from 61 companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pleskova's costs compare to other hematology & oncology specialists in Brooklyn?
Dr. Pleskova's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pleskova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Brooklyn
Browse hematology & oncology specialists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology